This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
May 9, 2012 /PRNewswire/ -- This Saturday
Reliv International, Inc. (NASDAQ: RELV), will host "The Science of LunaRich," an informational presentation featuring the scientists and leaders behind this important nutritional discovery. The event, which takes place at the Hilton Boston/
May 12 at
9:30 a.m., is free and open to the public.
LunaRich™ is a whole soy powder containing five to ten times more lunasin than the industry standard. Lunasin is a peptide found naturally in soy that scientists have identified as the key to many of soy's documented health benefits. These include cholesterol management, heart health and weight loss, among others.
Learn how LunaRich helps control cholesterol production in the liver, the source of over 80% of the body's cholesterol.
Speakers at Saturday's event include:
Dr. Carl Hastings, Reliv's Chief Scientific Officer
Dr. Alfredo Galvez, renowned research scientist
Ryan Schmidt, CEO of Soy Labs, LLC
Don Gibbons, Reliv Senior Vice President
"A growing body of research shows that the lunasin peptide is one of the most important bioactive components of soy," said Dr. Galvez. "In creating LunaRich for Reliv, we have maximized lunasin levels in a soy powder."
Dr. Galvez first discovered lunasin in 1996 during research at UC Berkley to improve the nutritional profile of soy protein. More than 40 peer-reviewed and published studies have documented lunasin's health benefits. Research by 21 institutions supported by 27 public and private funding sources has resulted in nine patents.
The amount of lunasin in soybeans varies significantly based on seed, soil and environment. To create LunaRich, specially selected soybeans grown exclusively for Reliv are refined to maximize levels of lunasin.